Medidata Unveils New Patient, Study, and Data Experiences at NEXT London 2025, Leveraging AI to Accelerate Innovation in Clinical Trials
Sir Chris Hoy, six-time Olympic cycling champion, to discuss his experience as a patient with Stage 4 cancer with Medidata Chief Patient Officer, Alicia Staley
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, is kicking off NEXT London 2025 at the Queen Elizabeth II Centre today. The event brings together world-leading experts and the biggest names in the life sciences industry to discuss the most topical issues about clinical trials.
NEXT London showcases how the Medidata Study, Data, and Patient Experiences centre on the full ecosystem of clinical trials - from development through commercialization - providing the digital solutions to support sites and sponsors to unify clinical trial processes, reduce costs, accelerate therapy development, and save patient lives. Powered by the world’s largest collection of anonymized and de-identified historical clinical trial data, AI continues to be a critical element of Medidata’s digital platform, allowing these experiences to be infused with machine learning and other technologies.
The conference features over 20 speakers including the CEO of Cogstate, Brad O’Connor; CEO of Click Therapeutics, David Benshoof Klein; Global Head of Clinical Data Management at Sanofi, Patrick Naldony; and Head of Biometrics at Autolus, Michael Zhang. In the closing keynote speech, six-time Olympic cycling champion Sir Chris Hoy, will explain the patient’s perspective and his views on healthcare innovation with Medidata’s Chief Patient Officer Alicia Staley.
“NEXT London 2025 continues to be one of the life science’s leading events in the UK, connecting colleagues from across the industry as we aim to transform the clinical trials landscape to support a healthier population and save lives,” said Jennifer Plumer, senior vice president, head of marketing, Medidata. “Sir Chris Hoy’s experiences are inspirational and understanding the patient’s perspective is vital for the successful design and management of clinical trials.”
The conference includes 20 interactive sessions and immersive experiences, allowing participants to see first-hand how Medidata’s digital solutions work in practice. Attendees have the opportunity to attend panel sessions where experts will discuss key trends in the sector, including How Industry Leaders Are Using AI Today.
NEXT London kicks off the 2025 Medidata NEXT global event series. To learn more, click here.
Contact:
Medidata PR
Analyst Relations